Correlation Between Capricor Therapeutics and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and HUTCHMED DRC, you can compare the effects of market volatilities on Capricor Therapeutics and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and HUTCHMED DRC.

Diversification Opportunities for Capricor Therapeutics and HUTCHMED DRC

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Capricor and HUTCHMED is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Capricor Therapeutics and HUTCHMED DRC

Given the investment horizon of 90 days Capricor Therapeutics is expected to generate 1.37 times more return on investment than HUTCHMED DRC. However, Capricor Therapeutics is 1.37 times more volatile than HUTCHMED DRC. It trades about -0.11 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.16 per unit of risk. If you would invest  2,146  in Capricor Therapeutics on August 29, 2024 and sell it today you would lose (240.00) from holding Capricor Therapeutics or give up 11.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Capricor Therapeutics  vs.  HUTCHMED DRC

 Performance 
       Timeline  
Capricor Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Capricor Therapeutics and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capricor Therapeutics and HUTCHMED DRC

The main advantage of trading using opposite Capricor Therapeutics and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind Capricor Therapeutics and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets